1.
Asghar K, Loya A. INDOLEAMINE 2,3 DIOXYGENASE AS AN IMMUNOTHERAPEUTIC TARGET BRINGS A NEW HOPE FOR CANCER PATIENTS. J Cancer Allied Spec [Internet]. 2018Sep.30 [cited 2021Sep.27];4(3). Available from: https://journals.sfu.ca/jcas/index.php/jcas/article/view/175